Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

Global tuberculosis control: lessons learnt and future prospects.

Lienhardt C, Glaziou P, Uplekar M, Lönnroth K, Getahun H, Raviglione M.

Nat Rev Microbiol. 2012 May 14;10(6):407-16. doi: 10.1038/nrmicro2797. Review.

PMID:
22580364
2.

Stopping tuberculosis in the 21st century: goals and strategies.

Onozaki I, Raviglione M.

Respirology. 2010 Jan;15(1):32-43. doi: 10.1111/j.1440-1843.2009.01673.x. Review.

PMID:
20199633
3.

Global epidemiology of tuberculosis: prospects for control.

Lönnroth K, Raviglione M.

Semin Respir Crit Care Med. 2008 Oct;29(5):481-91. doi: 10.1055/s-0028-1085700. Epub 2008 Sep 22. Review.

PMID:
18810682
4.

[Tuberculosis in Asia].

[No authors listed]

Kekkaku. 2002 Oct;77(10):693-7. Japanese.

PMID:
12440145
5.

TB and HIV: joint problems, joint solutions?

Elzinga G, Nunn P.

Bull World Health Organ. 2002;80(6):469-70. No abstract available.

6.

[Development of antituberculous drugs: current status and future prospects].

Tomioka H, Namba K.

Kekkaku. 2006 Dec;81(12):753-74. Review. Japanese.

PMID:
17240921
7.

[Fight against tuberculosis in the world].

El Kamel A, Joobeur S, Skhiri N, Cheikh Mhamed S, Mribah H, Rouatbi N.

Rev Pneumol Clin. 2015 Apr-Jun;71(2-3):181-7. doi: 10.1016/j.pneumo.2014.03.004. Epub 2014 May 28. Review. French.

PMID:
24878188
8.

Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally.

Dye C, Watt CJ, Bleed DM, Hosseini SM, Raviglione MC.

JAMA. 2005 Jun 8;293(22):2767-75.

PMID:
15941807
9.

Tuberculosis-a World Health Organization Perspective.

Sotgiu G, Sulis G, Matteelli A.

Microbiol Spectr. 2017 Jan;5(1). doi: 10.1128/microbiolspec.TNMI7-0036-2016. Review.

PMID:
28185618
10.

Tuberculosis: a new vision for the 21st century.

Small PM.

Kekkaku. 2009 Nov;84(11):721-6.

PMID:
19999594
12.

Tuberculosis as part of the natural history of HIV infection in developing countries.

Chamie G, Luetkemeyer A, Charlebois E, Havlir DV.

Clin Infect Dis. 2010 May 15;50 Suppl 3:S245-54. doi: 10.1086/651498. Review.

13.

Tuberculosis control in Latvia: integrated DOTS and DOTS-plus programmes.

Leimane V, Leimans J.

Euro Surveill. 2006;11(3):29-33.

PMID:
16567876
14.

CDC Grand Rounds: the TB/HIV syndemic.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2012 Jul 6;61(26):484-9.

15.

Tuberculosis vaccines: hopes and hurdles.

Ahsan MJ, Garg SK, Vashistha B, Sharma P.

Infect Disord Drug Targets. 2013 Oct;13(5):318-21. Review.

PMID:
24304353
16.

[The Dutch contribution to worldwide tuberculosis control: Royal Netherlands Association for the Prevention of Tuberculosis (KNCV) Tuberculosis Foundation].

Becx-Bleumink M, Gondrie PC, van Gorkom J.

Ned Tijdschr Geneeskd. 2003 Sep 20;147(38):1875-8. Dutch.

PMID:
14533503
17.

Tuberculosis into the 2010s: is the glass half full?

Ralph AP, Anstey NM, Kelly PM.

Clin Infect Dis. 2009 Aug 15;49(4):574-83. doi: 10.1086/600889. Review.

PMID:
19583517
18.

Critical evaluation of the Global DOTS Expansion Plan.

Enarson DA, Billo NE.

Bull World Health Organ. 2007 May;85(5):395-8; discussion 399-403.

19.

The epidemiology of tuberculosis in the United States.

Burzynski J, Schluger NW.

Semin Respir Crit Care Med. 2008 Oct;29(5):492-8. doi: 10.1055/s-0028-1085701. Epub 2008 Sep 22. Review.

PMID:
18810683
20.

Tuberculosis and HIV-infection in developing countries.

Broekmans JF.

Trop Geogr Med. 1991 Jul;43(3):S13-21.

PMID:
1687768

Supplemental Content

Support Center